CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity
Ji Min Kwon, Kang Yeun Pak, Jae Jung Lee, Min Sagong, Hyun Woong Kim
Korean J Ophthalmol. 2021;35(1):26-36.   Published online December 11, 2020
DOI: https://doi.org/10.3341/kjo.2020.0096

Excel Download

One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity
Korean Journal of Ophthalmology. 2021;35(1):26-36   Crossref logo
Link1 Link2 Link3

Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
Japanese Journal of Ophthalmology. 2013;57(4):365-371   Crossref logo
Link1 Link2 Link3

Re: Yamamoto et al.: One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy (Ophthalmology 2015;122:1866-72)
Ophthalmology. 2016;123(2):e13   Crossref logo
Link1 Link2

Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy
PLOS ONE. 2018;13(5):e0197042   Crossref logo
Link1

One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Ophthalmology. 2015;122(9):1866-1872   Crossref logo
Link1 Link2

Short-term efficacy of intravitreal aflibercept depending on subtypes of polypoidal choroidal vasculopathy: polypoidal choroidal neovascularization or idiopathic choroidal vasculopathy
Acta Ophthalmologica. 2016;94:   Crossref logo
Link1 Link2

Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy
PLOS ONE. 2020;15(6):e0235213   Crossref logo
Link1

One-Year Outcomes of Fixed-Dosing Aflibercept Therapy for Polypoidal Choroidal Vasculopathy: A Case Series
. 2020;   Crossref logo
Link1 Link2

One-year Outcomes of Fixed-Dosing Aflibercept Therapy for pre treated and naive polypoidal choroidal vasculopathy patient
. 2020;   Crossref logo
Link1 Link2

One-year Outcomes of Fixed-Dosing Aflibercept Therapy for pre treated and naive polypoidal choroidal vasculopathy patient
. 2021;   Crossref logo
Link1 Link2